Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
3.2
3.2
Journals
Infectious Disease Reports
Special Issues
Epidemiology and Prevention of Vaccine Preventable Diseases
share announcement

Epidemiology and Prevention of Vaccine Preventable Diseases

A special issue of Infectious Disease Reports (ISSN 2036-7449). This special issue belongs to the section "Immunology and Vaccines".

Deadline for manuscript submissions: closed (1 April 2023) | Viewed by 8185

Special Issue Editor

Dr. Daniela Loconsole

E-Mail Website
Guest Editor
Hygiene Section, Department of Biomedical Sciences and Human Oncology, University of Bari, 70124 Bari, Italy
Interests: health surveillance and promotion; molecular epidemiology; SARS-CoV-2; influenza; HIV; sexually transmitted infections; viral hepatitis infectious disease epidemiology; outbreak investigation; immunizations; epidemiology; antibiotic resistance; vaccine-preventable; infections; foodborne diseases; vector-borne disease; the effectiveness of vaccines; communication on vaccines and vaccinations

Special Issue Information

Dear Colleagues,

Since the diffusion of SARS-CoV-2 infection outside China in 2019, the world has experienced the worst health crisis of the past few decades. SARS-CoV-2’s spread has caused a change in the epidemiology of many pathogens, such as influenza viruses. The COVID-19 pandemic risks disrupting routine immunization activities, causing a drop in vaccine coverage worldwide. Moreover, the war in Ukraine also represents a public health threat in Europe and could trigger the diffusion of VPDs and the occurrence of outbreaks. Any disruption of immunization services could lead to an accumulation of susceptible individuals and an increased risk of outbreaks caused by vaccine-preventable diseases (VPDs).

The Special Issue “Epidemiology and Prevention of Vaccine-Preventable Diseases”, will collect articles in the field of the epidemiology of infectious diseases, including biomedical, environmental, and clinical aspects, and developments of new preventive strategies to increase and maintain a high level of vaccine coverage rates, including sociobehavioral, economic, and communicative aspects.

You are welcome to send short papers, original articles, and reviews for submissions to the Editorial Office for evaluation of their suitability.

Dr. Daniela Loconsole
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Infectious Disease Reports is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • infectious disease
  • epidemiology
  • vaccine
  • vaccine coverage
  • preventive strategies

Published Papers (3 papers)

Download All Papers
Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Research

12 pages, 296 KiB  
Article
Willingness of Healthcare Workers to Recommend or Receive a Third COVID-19 Vaccine Dose: A Cross-Sectional Study from Jordan
by Mohammad Abu Lubad, Munir A. Abu-Helalah, Israa F. Alahmad, Malak M. Al-Tamimi, Mohammad S. QawaQzeh, Ahlam M. Al-kharabsheh, Hamed Alzoubi, Ahmad H. Alnawafleh and Khalid A. Kheirallah
Infect. Dis. Rep. 2023, 15(2), 210-221; https://doi.org/10.3390/idr15020022 - 06 Apr 2023
Cited by 3 | Viewed by 2347
Abstract
Background: The availability of COVID-19 vaccines worldwide necessitates measuring healthcare workers’ (HCWs’) willingness to recommend or receive these vaccines. Therefore, we conducted a local study in Jordan to assess HCWs’ willingness to recommend or receive a third dose of a COVID-19 vaccine and [...] Read more.
Background: The availability of COVID-19 vaccines worldwide necessitates measuring healthcare workers’ (HCWs’) willingness to recommend or receive these vaccines. Therefore, we conducted a local study in Jordan to assess HCWs’ willingness to recommend or receive a third dose of a COVID-19 vaccine and the predictors of such a decision. A cross-sectional study investigated Jordanian HCWs’ willingness regarding a third dose of a COVID-19 vaccine using a self-administered online questionnaire through WhatsApp, a mobile phone application. A total of 300 HCWs participated in the current study. Of these HCWs, 65.3% were physicians, 25.3% were nurses, and 9.3% were pharmacists. HCWs’ overall willingness regarding a third vaccine dose was 68.4% (49.4% certainly and 19.0% probably), whereas the overall willingness of HCWs to recommend a third dose to their patients was 73.3% (49.0% certainly and 24.3% probably). Males had significantly higher willingness than females (82.1% vs. 60.1%, p < 0.05). Physicians reported more willingness than nurses and pharmacists. HCWs’ willingness was not significantly affected by direct contact with a patient infected with COVID-19 or by a personal history of COVID-19 infection. Only 31% of HCWs were certainly willing to recommend the vaccine to their patients with chronic diseases, and only 28% of the participants were certainly willing to recommend it to people aged 65 or older. HCWs’ willingness to receive a third dose of a COVID-19 vaccine is limited in Jordan. This has affected their certainty in recommending this vaccine to their patients or people older than 60. Decision-makers and health-promotion programs in Jordan should focus on addressing this public health problem. Full article
(This article belongs to the Special Issue Epidemiology and Prevention of Vaccine Preventable Diseases)
16 pages, 941 KiB  
Article
Willingness to Pay (WTP) for COVID-19 Vaccine Booster Dose and Its Determinants in Indonesia
by Harapan Harapan, Malik Sallam, Raisha Fathima, Hendrix Indra Kusuma, Samsul Anwar, Widhy Yudistira Nalapraya, Adityo Wibowo, Ketut Dewi Kumara Wati, Ayunda Medina, Anna Hanifa Defrita, Yesi Astri, Arie Prasetyowati, Nurfarahin Nurfarahin, Afriyani Khusna, Setya Oktariana, Sarifuddin Anwar, Milza Oka Yussar, Siti Khotimah, Bahagia Willibrordus Maria Nainggolan, Putri Rizki Amalia Badri, Raden Argarini, Wira Winardi, Khan Sharun, Rosaria Indah, Yogambigai Rajamoorthy, Abram L. Wagner and Mudatsir Mudatsiradd Show full author list remove Hide full author list
Infect. Dis. Rep. 2022, 14(6), 1017-1032; https://doi.org/10.3390/idr14060101 - 11 Dec 2022
Cited by 3 | Viewed by 2917
Abstract
Willingness to pay (WTP) for booster doses of coronavirus disease 2019 (COVID-19) vaccines is an under studied research topic. Therefore, the current study aimed to investigate the WTP for the booster doses of COVID-19 vaccines and its predictors in Indonesia using an online [...] Read more.
Willingness to pay (WTP) for booster doses of coronavirus disease 2019 (COVID-19) vaccines is an under studied research topic. Therefore, the current study aimed to investigate the WTP for the booster doses of COVID-19 vaccines and its predictors in Indonesia using an online survey distributed all over the provinces of this low-middle-income country. The WTP was evaluated using a basic dichotomous contingent valuation approach, and its associated determinants were evaluated using a linear regression model. Out of 2935 responders, 66.2% (1942/2935) were willing to pay for a booster dose of the COVID-19 vaccine. The majority of respondents (63.5%) were willing to pay within a price range of 100,000–500,000 Indonesian rupiah (IDR), i.e., USD 6.71–33.57. Being older than 40 years, having a higher educational level, having a higher income, knowing and understanding that booster doses were important, and having a vaccine status that is certified halal (permissible in Islamic law), were all associated with a higher WTP for the booster dose of COVID-19 vaccines. The study findings imply that the WTP for a booster dose of COVID-19 vaccination in Indonesia is lower compared to acceptance of vaccines provided free of charge. This WTP data can be utilized to develop a pricing scheme for the booster doses of COVID-19 vaccination in the country with potential benefits in other low-income countries. The government may be required to provide subsidies for the herd immunity vaccination process to proceed as anticipated. Furthermore, the public community must be educated on the importance of vaccination as well as the fact that the COVID-19 epidemic is far from being over. Full article
(This article belongs to the Special Issue Epidemiology and Prevention of Vaccine Preventable Diseases)
9 pages, 4536 KiB  
Article
The Importance of COVID-19/Influenza Vaccines Co-Administration: An Essential Public Health Tool
by Roberto Venuto, Ioselita Giunta, Rosaria Cortese, Federica Denaro, Giuseppe Pantò, Antonino Privitera, Smeralda D’Amato, Cristina Genovese, Vincenza La Fauci, Francesco Fedele, Concetta Ceccio, Raffaele Squeri and Alessio Facciolà
Infect. Dis. Rep. 2022, 14(6), 987-995; https://doi.org/10.3390/idr14060098 - 05 Dec 2022
Cited by 4 | Viewed by 2131
Abstract
Vaccine co-administration is an important tool with several advantages for public health, among which is the increase of vaccination coverage, as well as economic and logistical benefits. The purpose of this study was to assess and compare the immune response to the COVID-19 [...] Read more.
Vaccine co-administration is an important tool with several advantages for public health, among which is the increase of vaccination coverage, as well as economic and logistical benefits. The purpose of this study was to assess and compare the immune response to the COVID-19 first booster dose in healthcare workers (HCWs) who chose co-administration and in HCWs who received only COVID-19 vaccination and to investigate personal opinions about the experience of co-administration. We carried out a retrospective analysis involving two groups of HCWs, both vaccinated with the complete primary cycle and the first booster dose of the COVID-19 vaccine, but one of them was also vaccinated, at the same time as the first booster dose, with the influenza vaccine. Active phone calls were also performed, and specific questions about the onset of side effects and general opinions were asked. A good immune response was found in both two groups without any statistically significant difference in the immune response. No severe reactions occurred in either group. A greater part of the sample was completely satisfied, and they would do it again. Our findings are totally in favor of the co-administration, considering the many positive aspects provided by administering, at the same time, more vaccines. Full article
(This article belongs to the Special Issue Epidemiology and Prevention of Vaccine Preventable Diseases)
►▼ Show Figures

Figure 1

Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-3
Back to TopTop